Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,422 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of neoadjuvant nab-paclitaxel plus gemcitabine therapy in patients with borderline resectable pancreatic cancer: A multicenter single-arm phase II study (NAC-GA trial).
Okada KI, Kimura K, Yamashita YI, Shibuya K, Matsumoto I, Satoi S, Yoshida K, Kodera Y, Akahori T, Hirono S, Eguchi H, Asakuma M, Tani M, Hatano E, Ikoma H, Ohira G, Hayashi H, Wan K, Shimokawa T, Kawai M, Yamaue H; NAC‐GA investigators. Okada KI, et al. Among authors: hayashi h. Ann Gastroenterol Surg. 2023 Jul 8;7(6):997-1008. doi: 10.1002/ags3.12712. eCollection 2023 Nov. Ann Gastroenterol Surg. 2023. PMID: 37927936 Free PMC article.
Preoperative platelet-to-lymphocyte ratio can predict recurrence beyond the Milan criteria after hepatectomy for patients with hepatocellular carcinoma.
Kaida T, Nitta H, Kitano Y, Yamamura K, Arima K, Higashi T, Taki K, Nakagawa S, Okabe H, Hayashi H, Imai K, Hashimoto D, Yamashita YI, Chikamoto A, Ishiko T, Beppu T, Baba H. Kaida T, et al. Among authors: hayashi h. Hepatol Res. 2017 Sep;47(10):991-999. doi: 10.1111/hepr.12835. Epub 2016 Dec 21. Hepatol Res. 2017. PMID: 28000365
The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma.
Beppu T, Nakagawa S, Nitta H, Okabe H, Kaida T, Imai K, Hayashi H, Koga Y, Kuramoto K, Hashimoto D, Yamashita YI, Chikamoto A, Ishiko T, Baba H. Beppu T, et al. Among authors: hayashi h. J Clin Transl Hepatol. 2017 Jun 28;5(2):165-168. doi: 10.14218/JCTH.2016.00055. Epub 2017 May 10. J Clin Transl Hepatol. 2017. PMID: 28660154 Free PMC article. Review.
Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination.
Kuramoto K, Beppu T, Nitta H, Imai K, Masuda T, Miyata T, Koga Y, Kitano Y, Kaida T, Nakagawa S, Okabe H, Hayashi H, Hashimoto D, Yamashita YI, Chikamoto A, Kikuchi K, Baba H. Kuramoto K, et al. Among authors: hayashi h. Anticancer Res. 2018 Jan;38(1):525-531. doi: 10.21873/anticanres.12254. Anticancer Res. 2018. PMID: 29277819
Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with pancreatic neuroendocrine tumors.
Matsumoto T, Okabe H, Yamashita YI, Yusa T, Itoyama R, Nakao Y, Yamao T, Umzaki N, Tsukamoto M, Kitano Y, Miyata T, Arima K, Nitta H, Hayashi H, Imai K, Chikamoto A, Baba H. Matsumoto T, et al. Among authors: hayashi h. Surg Today. 2019 Jan;49(1):21-26. doi: 10.1007/s00595-018-1703-2. Epub 2018 Aug 20. Surg Today. 2019. PMID: 30128759
Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma.
Okabe H, Yoshizumi T, Yamashita YI, Imai K, Hayashi H, Nakagawa S, Itoh S, Harimoto N, Ikegami T, Uchiyama H, Beppu T, Aishima S, Shirabe K, Baba H, Maehara Y. Okabe H, et al. Among authors: hayashi h. PLoS One. 2018 Sep 14;13(9):e0203856. doi: 10.1371/journal.pone.0203856. eCollection 2018. PLoS One. 2018. PMID: 30216361 Free PMC article.
6,422 results